Impax Laboratories, Inc. IPXL entered into definitive agreements with Teva Pharmaceutical Industries Ltd. TEVA and Allergan plc AGN related to the acquisition of several generic products across solid oral, inhalable, injectable and topical dosage ... Zacks.com, 2 days ago
Dr. Reddy's Laboratories, GSK end tie-up in emerging markets - Livemint.com, 1 hour ago
Dr. Reddys Lab ends in green; inks pact with Teva - India Infoline, 1 week ago
'Hitachi Kyoto University Laboratory' to Promote Joint-Research on the 'Exploration of Basics and Theory based on an Understanding of Humans and Culture'
JCN Newswire 2016-06-23 TOKYO, Jun 23, 2016 - (JCN Newswire) - Kyoto University and Hitachi, Ltd. (TSE: 6501; "Hitachi") today announced the establishment of the "Hitachi Kyoto University Laboratory" ("the Laboratory"), a joint research ...BizWire Express, 1 day ago HITACHI : June 23, 2016Hitachi Kyoto University Laboratory to promote joint-research on the exploration of basics and theory based on an understanding of humans and culture 4 Traders, 1 day ago HITACHI : 'Hitachi Kyoto University Laboratory' to promote joint-research on the 'exploration of basics and theory based on an understanding of humans and culture' 4 Traders, 6 hours ago HITACHI : Kyoto University Laboratory' to promote joint-research on the 'exploration of basics and theory based on an understanding of humans and culture' 4 Traders, 8 hours ago
More from: JARN, JARN...and 13 other sources
Impax Laboratories Inc. will buy a portfolio of drugs from Teva Pharmaceutical Industries Ltd. and Allergan Plc for $586 million as the two larger pharmaceutical companies divest products to gain antitrust approval for their own deal. The Hayward, ...Bloomberg, 2 days ago Teva, Allergan to divest generics to Impax Labs for about $586 mn Domain-B, 9 hours ago Impax to acquire generics from Teva, Allergan Chain Drug Review, 2 days ago Impax buys generic drugs from Teva, Allergan for $586 million Reuters UK, 3 days ago
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] SEC Accession No. 0001193125-16-630015 Filing Date 2016-06-23 2016-06-23 15:27:08 Period of Report 2016-03-31 Filing Date Changed 2016-06-23 ...SEC Filings, 1 day ago Dr Reddys Laboratories Ltd Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16] (Jun. 14, 2016) Equities.com, 17 hours ago Dr Reddys Laboratories appoints Hans Peter Hasler as Additional Director India Infoline, 6 days ago DR REDDY LABORATORIES : Reddys Laboratories appoints Hans Peter Hasler as Additional Director 4 Traders, 4 days ago
More from: , Equity Bulls...and 1 other sources
CHAPEL HILL, NC -- With no laboratory test available to diagnose functional gastrointestinal disorders, proper diagnostic criteria are critical for clinicians to make an accurate determination of what ails their patients. Several University of North ...Infrosoft, 3 days ago Anteo Diagnostics Ltd to co-develop award winning heart attack prevention test Proactive Investors Australia, 1 week ago
Omkar Speciality Chemicals has informed the exchanges that Lasa Laboratory Pvt Ltd, a wholly-owned subsidiary, has purchased a plot measuring 5,200 sq mt, in the Industrial Zone of Mahad Industrial Area, Birwadi, Raigad, Maharashtra. The plot, which is ...Business Line, 1 week ago Omkar Speciality Chemicals Ltd announces purchase of Plot of Land by Lasa Laboratory Private Limited Equity Bulls, 1 week ago
Caplin Point Laboratories Ltd has informed BSE that Mr. D. P. Mishra, Whole-time Director of the Company resigned from the position of the Whole-time Director from the Close of business hours on April 30, 2016 (Since, his term of Whole-time Director expires ...Money Control, 1 month ago Makers Laboratories recommends dividend Money Control, 4 weeks ago Coral Laboratories to consider dividend Money Control, 1 month ago Caplin Point Laboratories to consider final dividend Money Control, 1 month ago
JHS Svendgaard Laboratories Ltd has informed BSE that a meeting of the Allotment Committee has been scheduled to be held on May 26, 2016 for consideration of conversion of Fully Convertible Warrants into Equity Shares to the respective allottees.Money Control, 1 month ago Brooks Laboratories' board meeting on May 27, 2016 Money Control, 1 month ago Ortin Laboratories' board meeting on May 30, 2016 Money Control, 1 month ago Zenotech Laboratories' board meeting on May 21, 2016 Money Control, 1 month ago
Posted On: 2016-06-22 19:38:46 The Register of Members & Share Transfer Books of Unichem Laboratories Ltd will remain closed from July 18, 2016 to July 23, 2016 (both days inclusive) for the purpose of 53rd Annual General Meeting (AGM) of the ...Equity Bulls, 1 day ago Chemo Pharma Laboratories: Outcome of board meeting Money Control, 3 weeks ago Jyothy Laboratories: Outcome of board meeting Money Control, 1 month ago Unichem Laboratories: Outcome of board meeting Money Control, 1 month ago
MUMBAI, May 12 (Reuters) - Dr Reddy's Laboratories Ltd, India's second-largest drugmaker, reported a muchlower-than-expected fourth-quarter net profit on Thursday, hitby a write-off related to its business in Venezuela. Pharmaceutical companies, including Dr ...Sify, 1 month ago Dr Reddy's Labs fourth quarter profit slumps on Venezuela write-off Business Standard, 1 month ago
on your WebpageAdd Widget >Get your members hooked!